Click here to get full coverage on Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Yahoo Finance

Here's Why You Should Hold OPK Stock in Your Portfolio for Now  Yahoo Finance

Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Yahoo Finance

Click here to get full coverage on OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened - MarketBeat

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened  MarketBeat

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened - MarketBeat

Click here to get full coverage on OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan

OPKO Health (NASDAQ: OPK) director reports initial common stock holdings  Stock Titan

OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan

Click here to get full coverage on OPKO Health: The Waiting Game Continues (NASDAQ:OPK) - Seeking Alpha

OPKO Health: The Waiting Game Continues (NASDAQ:OPK)  Seeking Alpha

OPKO Health: The Waiting Game Continues (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on Barrington lowers PT on OPKO Health (OPK), keeps a buy - MSN

Barrington lowers PT on OPKO Health (OPK), keeps a buy  MSN

Barrington lowers PT on OPKO Health (OPK), keeps a buy - MSN

Click here to get full coverage on OPK May 2026 1.000 put (OPK260515P00001000) Interactive Stock Chart - Yahoo! Finance Canada

OPK May 2026 1.000 put (OPK260515P00001000) Interactive Stock Chart  Yahoo! Finance Canada

OPK May 2026 1.000 put (OPK260515P00001000) Interactive Stock Chart - Yahoo! Finance Canada

Click here to get full coverage on Opko Health Inc. (OPK) builds value through partnerships and innovation - MSN

Opko Health Inc. (OPK) builds value through partnerships and innovation  MSN

Opko Health Inc. (OPK) builds value through partnerships and innovation - MSN

Click here to get full coverage on OPK Apr 2026 1.500 call (OPK260417C00001500) Interactive Stock Chart - Yahoo! Finance Canada

OPK Apr 2026 1.500 call (OPK260417C00001500) Interactive Stock Chart  Yahoo! Finance Canada

OPK Apr 2026 1.500 call (OPK260417C00001500) Interactive Stock Chart - Yahoo! Finance Canada

Click here to get full coverage on How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Yahoo Finance

How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals  Yahoo Finance

How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Yahoo Finance

Click here to get full coverage on Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns - Yahoo Finance

Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns  Yahoo Finance

Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns - Yahoo Finance

Click here to get full coverage on Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Yahoo Finance

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development  Yahoo Finance

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Yahoo Finance

Click here to get full coverage on OPK May 2026 1.500 call (OPK260515C00001500) interactive stock chart - uk.finance.yahoo.com

OPK May 2026 1.500 call (OPK260515C00001500) interactive stock chart  uk.finance.yahoo.com

OPK May 2026 1.500 call (OPK260515C00001500) interactive stock chart - uk.finance.yahoo.com

Click here to get full coverage on OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade - Yahoo Finance

The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade  Yahoo Finance

The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade - Yahoo Finance

Click here to get full coverage on OPKO Health (NASDAQ:OPK investor five-year losses grow to 58% as the stock sheds US$64m this past week - Yahoo Finance

OPKO Health (NASDAQ:OPK investor five-year losses grow to 58% as the stock sheds US$64m this past week  Yahoo Finance

OPKO Health (NASDAQ:OPK investor five-year losses grow to 58% as the stock sheds US$64m this past week - Yahoo Finance

Click here to get full coverage on Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance

Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates  Yahoo Finance

Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance

Click here to get full coverage on Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance - Yahoo Finance

Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance  Yahoo Finance

Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance - Yahoo Finance

Click here to get full coverage on 44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance

44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently  Yahoo Finance

44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance

Click here to get full coverage on Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News - Quiver Quantitative

Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News  Quiver Quantitative

Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News - Quiver Quantitative

Click here to get full coverage on OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Yahoo Finance

OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands  Yahoo Finance

OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Yahoo Finance

Click here to get full coverage on OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings - Yahoo Finance

OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings  Yahoo Finance

OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings - Yahoo Finance

Click here to get full coverage on Opko’s OPK-88006 shows hepatoprotection in MASH - BioWorld MedTech

Opko’s OPK-88006 shows hepatoprotection in MASH  BioWorld MedTech

Opko’s OPK-88006 shows hepatoprotection in MASH - BioWorld MedTech

Click here to get full coverage on OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance

OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla  Yahoo Finance

OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance

Click here to get full coverage on Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - Yahoo Finance

Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals  Yahoo Finance

Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - Yahoo Finance

Click here to get full coverage on OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - simplywall.st

OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives  simplywall.st

OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - simplywall.st

Click here to get full coverage on Opko Health (OPK) director adds 10,000 shares in open-market buy - Stock Titan

Opko Health (OPK) director adds 10,000 shares in open-market buy  Stock Titan

Opko Health (OPK) director adds 10,000 shares in open-market buy - Stock Titan

Click here to get full coverage on Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook? - simplywall.st

Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook?  simplywall.st

Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook? - simplywall.st

Click here to get full coverage on OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics - Yahoo Finance

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics  Yahoo Finance

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics - Yahoo Finance

Click here to get full coverage on OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - simplywall.st

OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up  simplywall.st

OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - simplywall.st

Click here to get full coverage on OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts  Yahoo Finance

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance

Click here to get full coverage on OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK) - Seeking Alpha

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)  Seeking Alpha

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance

Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)?  Yahoo Finance

Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance

Click here to get full coverage on OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance

OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1  Yahoo Finance

OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance

Click here to get full coverage on OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - OPKO Health, Inc.

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results  OPKO Health, Inc.

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - OPKO Health, Inc.

Click here to get full coverage on OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands - Yahoo Finance

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands  Yahoo Finance

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands - Yahoo Finance

Click here to get full coverage on A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30 - simplywall.st

A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30  simplywall.st

A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30 - simplywall.st

Click here to get full coverage on OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17 - Stock Titan

OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17  Stock Titan

OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17 - Stock Titan

Click here to get full coverage on OPKO Health (NASDAQ:OPK) Director Buys $11,400.00 in Stock - MarketBeat

OPKO Health (NASDAQ:OPK) Director Buys $11,400.00 in Stock  MarketBeat

OPKO Health (NASDAQ:OPK) Director Buys $11,400.00 in Stock - MarketBeat

Click here to get full coverage on Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com

Opko Health CEO Phillip Frost buys $737,747 in OPK stock  Investing.com

Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com

Click here to get full coverage on OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board - Stock Titan

OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board  Stock Titan

OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board - Stock Titan

Click here to get full coverage on OPKO Health inks $1B-plus Regeneron antibody pact in Q4 update - Stock Titan

OPKO Health inks $1B-plus Regeneron antibody pact in Q4 update  Stock Titan

OPKO Health inks $1B-plus Regeneron antibody pact in Q4 update - Stock Titan

Click here to get full coverage on OPKO HEALTH Earnings Results: $OPK Reports Quarterly Earnings - Quiver Quantitative

OPKO HEALTH Earnings Results: $OPK Reports Quarterly Earnings  Quiver Quantitative

OPKO HEALTH Earnings Results: $OPK Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26  OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - OPKO Health, Inc.

Click here to get full coverage on OPKO Health (NASDAQ: OPK) in Regeneron deal: $7M upfront, up to $200M per molecule - Stock Titan

OPKO Health (NASDAQ: OPK) in Regeneron deal: $7M upfront, up to $200M per molecule  Stock Titan

OPKO Health (NASDAQ: OPK) in Regeneron deal: $7M upfront, up to $200M per molecule - Stock Titan

Click here to get full coverage on Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares - simplywall.st

Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares  simplywall.st

Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares - simplywall.st

Click here to get full coverage on OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Should You Sell? - MarketBeat

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Should You Sell?  MarketBeat

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Should You Sell? - MarketBeat

Click here to get full coverage on Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025? - simplywall.st

Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025?  simplywall.st

Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025? - simplywall.st

Click here to get full coverage on Daily oral PTH tablet targets relief from hypoparathyroidism injections - Stock Titan

Daily oral PTH tablet targets relief from hypoparathyroidism injections  Stock Titan

Daily oral PTH tablet targets relief from hypoparathyroidism injections - Stock Titan

Click here to get full coverage on OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages  MarketBeat

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Click here to get full coverage on Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now  Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Yahoo Finance

Click here to get full coverage on Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - TradingView

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?  TradingView

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - TradingView

Click here to get full coverage on Earnings Breakdown: OPKO Health Q4 - Benzinga

Earnings Breakdown: OPKO Health Q4  Benzinga

Earnings Breakdown: OPKO Health Q4 - Benzinga

Click here to get full coverage on OPK: Therapeutics-focused strategy, key partnerships, and innovative pipeline drive growth - TradingView

OPK: Therapeutics-focused strategy, key partnerships, and innovative pipeline drive growth  TradingView

OPK: Therapeutics-focused strategy, key partnerships, and innovative pipeline drive growth - TradingView

Click here to get full coverage on Income Statement - OPKO Health, Inc.

Income Statement - OPKO Health, Inc.

Click here to get full coverage on 5 Best Ovulation Tests to Find Your Fertile Days, Based on Our Testing - The Bump

5 Best Ovulation Tests to Find Your Fertile Days, Based on Our Testing  The Bump

5 Best Ovulation Tests to Find Your Fertile Days, Based on Our Testing - The Bump

Click here to get full coverage on OPKO Health: The Lab Sale Brings Focus, But Execution Still Key (NASDAQ:OPK) - Seeking Alpha

OPKO Health: The Lab Sale Brings Focus, But Execution Still Key (NASDAQ:OPK)  Seeking Alpha

OPKO Health: The Lab Sale Brings Focus, But Execution Still Key (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - OPKO Health, Inc.

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference  OPKO Health, Inc.

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - OPKO Health, Inc.

Click here to get full coverage on OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada

OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus  Investing.com Canada

OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada

Click here to get full coverage on OPKO Health (OPK) Q4 2025 Earnings Call Transcript - AOL.com

OPKO Health (OPK) Q4 2025 Earnings Call Transcript  AOL.com

OPKO Health (OPK) Q4 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on Russia’s struggle to modernize its military industry | The impact of sanctions and war, and how the OPK is adapting - Chatham House

Russia’s struggle to modernize its military industry | The impact of sanctions and war, and how the OPK is adapting  Chatham House

Russia’s struggle to modernize its military industry | The impact of sanctions and war, and how the OPK is adapting - Chatham House

Click here to get full coverage on BioReference Lab Sale Might Change The Case For Investing In OPKO Health (OPK) - Sahm

BioReference Lab Sale Might Change The Case For Investing In OPKO Health (OPK)  Sahm

BioReference Lab Sale Might Change The Case For Investing In OPKO Health (OPK) - Sahm

Click here to get full coverage on With OPKO Health Stock Sliding, Have You Assessed The Risk? - trefis.com

With OPKO Health Stock Sliding, Have You Assessed The Risk?  trefis.com

With OPKO Health Stock Sliding, Have You Assessed The Risk? - trefis.com

Click here to get full coverage on OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - OPKO Health, Inc.

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit  OPKO Health, Inc.

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - OPKO Health, Inc.

Click here to get full coverage on OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations - Quiver Quantitative

OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations  Quiver Quantitative

OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations - Quiver Quantitative

Click here to get full coverage on Phillip Frost Buys Handful Of Shares In OPKO Health - Yahoo Finance

Phillip Frost Buys Handful Of Shares In OPKO Health  Yahoo Finance

Phillip Frost Buys Handful Of Shares In OPKO Health - Yahoo Finance

Click here to get full coverage on OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results - Yahoo Finance

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results  Yahoo Finance

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results - Yahoo Finance

Click here to get full coverage on OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt  simplywall.st

OPK

Price Chart

Key Statistics

Technicals

About OPK

Latest News

Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Yahoo Finance

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened - MarketBeat

OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan

Advanced Charts

Top Gainers

Top Losers